Tolerability and Safety Profile of a New Brand-Generic Product of Glatiramer Acetate in Iranian Patients with Relapsing-Remitting Multiple Sclerosis: An Observational Cohort Study(...

por Abolfazli, Roya, Pournourmohammadi, Shirin, Shamshiri, Ahmadreza, Samadzadeh, Sara
Publicado 2018

Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva(®)) in Patients with Multiple Sclerosis: An Observational Retrospective Study

por Abolfazli, Roya, Sahraian, Mohammad Ali, Tayebi, Atefeh, Kafi, Hamidreza, Samadzadeh, Sara
Publicado 2023

Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta

por Abolfazli, Roya, Elyasi, Azam, Javadi, Mohammad Reza, Gholami, Kheirollah, Torkamandi, Hassan, Amir-Shahkarami, Mohammad, Etemadifar, Masoud, Nasr, Zahra
Publicado 2014

A Comparison Study of Efficacy and Safety of a Biosimilar Form of Intramuscular Βeta-interferon I-a Versus the Reference Product: A Randomized Controlled Clinical Trial in Iran

por Nabavi, Seyed Massood, Abolfazli, Roya, Etemadrezaei, Ali, Hosseini, Hamed, Moradi, Nahid, Shahriari, Sanaz, Mehdipour, Baharak, Shekarchi, Babak, Soltanzadeh, Akbar
Publicado 2019

Prevalence of Sexual Dysfunction and Related Risk Factors in Men with Multiple Sclerosis in Iran: A Multicenter Study

por Nabavi, Seyed Massood, Dastoorpoor, Maryam, Majdinasab, Nastaran, Khodadadi, Narges, Khanjani, Narges, Sekhavatpour, Zohreh, Zamanian, Maryam, Kazemian, Sasan, Eftekhari, Amir Ebrahim, Ashtari, Fereshteh, Abolfazli, Roya, Jalili, Mahdi, Ghaedi, Gholamhossein, Ghalianchi, Hamid Reza
Publicado 2021